These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Scopolamine induces up-regulation of nicotinic receptors in intact brain but not in nucleus basalis lesioned rats.
    Author: Vige X, Briley M.
    Journal: Neurosci Lett; 1988 Jun 07; 88(3):319-24. PubMed ID: 3386878.
    Abstract:
    The effect of chronic scopolamine treatment on muscarinic and nicotinic receptors in frontoparietal cortex in rats was investigated. Administration of the muscarinic antagonist, scopolamine (10 mg/kg i.p./day) for 21 days, produced a significant increase in the density of both muscarinic and nicotinic receptors by 27.7% and 12.1% respectively as measured by the specific binding of (-)-[3H]quinuclidinylbenzilate and (-)-[3H]-nicotine. There was no modification in the affinities for these ligands. Rats, bilaterally lesioned with ibotenic acid at the level of nucleus basalis of Meynert, which innervates the frontoparietal cortex, showed no up-regulation of cortical nicotinic receptors after chronic scopolamine treatment, suggesting the importance of the synaptic integrity in the regulation mechanism.
    [Abstract] [Full Text] [Related] [New Search]